Skip to content

Pravastatin

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia.

United States
$5
per month
India
$5
per month
You save
−4%
save $0/mo · 4% cheaper
9.4M US scripts/yr$2.3M potential annual savings$50.7M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC23H36O7

SMILES: CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O

Compare the price
US price$5per month
India price$5per month
You save$04% less

Based on 30 units per month. US $0.18 vs India $0.17 per unit.

Total over 1 periodSave $0$5$5
The bigger picture

Pravastatin is filled about 9.4M times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$50.7M
If sourced from India
$48.5M
Potential annual savings
$2.3M
4%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.